ATX–LPA signaling is involved in breast cancer metastasis, but it also promotes osteolytic bone metastasis when LPA1 is overexpressed in the MAD-BO2 breast cancer cell line [37,137]. This evidence concerns the gene LPAR1 and breast carcinoma.